Saxagliptin/Dapagliflozin Is Non-inferior to Insulin Glargine in Terms of β-Cell Function in Subjects with Latent Autoimmune Diabetes in Adults: A 12-Month, Randomized, Comparator-Controlled Pilot Study

By
Jamie Kang
-
0
35
Investigators compared the efficacy and safety of saxagliptin/dapagliflozin and insulin glargine in people with latent autoimmune diabetes in adults.
[Diabetes Obesity & Metabolism]
Abstract